Sanofi, OpenAI, Formation Bio launch Muse, an AI tool for patient recruitmentnews2024-11-12T12:00:23+00:00November 12th, 2024|Endpoints News|
Novartis pays $150M upfront to Schrödinger in new drug dealnews2024-11-12T11:50:06+00:00November 12th, 2024|Endpoints News|
GSK acquires Parkinson’s small molecule from Vesaliusnews2024-11-12T11:30:30+00:00November 12th, 2024|Endpoints News|
Neurogene’s stock falls in post-market trading after early data in Rett syndromenews2024-11-12T05:16:30+00:00November 12th, 2024|Endpoints News|
23andMe to shut down its therapeutics divisionnews2024-11-11T23:44:13+00:00November 11th, 2024|Endpoints News|
Rapt cuts immunology program following clinical holdsnews2024-11-11T20:33:45+00:00November 11th, 2024|Endpoints News|
FDA lifts hold on Novavax vaccines after adverse event reclassified as ALSnews2024-11-11T18:25:04+00:00November 11th, 2024|Endpoints News|
Thermo Fisher consolidates viral vector work in Massachusetts, cuts 160 workers news2024-11-11T18:10:32+00:00November 11th, 2024|Endpoints News|
Yorvipath’s approval showcases biopharma’s interest in rare endocrine disordernews2024-11-11T16:15:06+00:00November 11th, 2024|Endpoints News|
Assertio considers legal options against activist investor accusing company of fraudnews2024-11-11T16:04:30+00:00November 11th, 2024|Endpoints News|
